{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:11:15Z","timestamp":1779149475948,"version":"3.51.4"},"reference-count":76,"publisher":"American Society for Clinical Investigation","issue":"12","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["DK-106364"],"award-info":[{"award-number":["DK-106364"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["DK,059637"],"award-info":[{"award-number":["DK,059637"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["DK-020593"],"award-info":[{"award-number":["DK-020593"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,22]]},"abstract":"<jats:p>Several studies have associated the presence of residual insulin secretion capability (also referred to as being C-peptide positive) with lower risk of insulin-induced hypoglycemia in patients with type 1 diabetes (T1D), although the reason is unclear. We tested the hypothesis that C-peptide infusion would enhance glucagon secretion in response to hyperinsulinemia during euglycemic and hypoglycemic conditions in dogs (5 male\/4 female). After a 2-hour basal period, an intravenous (IV) infusion of insulin was started, and dextrose was infused to maintain euglycemia for 2 hours. At the same time, an IV infusion of either saline (SAL) or C-peptide (CPEP) was started. After this euglycemic period, the insulin and SAL\/CPEP infusions were continued for another 2 hours, but the glucose was allowed to fall to approximately 50 mg\/dL. In response to euglycemic-hyperinsulinemia, glucagon secretion decreased in SAL but remained unchanged from the basal period in CPEP condition. During hypoglycemia, glucagon secretion in CPEP was 2 times higher than SAL, and this increased net hepatic glucose output and reduced the amount of exogenous glucose required to maintain glycemia. These data suggest that the presence of C-peptide during IV insulin infusion can preserve glucagon secretion during euglycemia and enhance it during hypoglycemia, which could explain why T1D patients with residual insulin secretion are less susceptible to hypoglycemia.<\/jats:p>","DOI":"10.1172\/jci.insight.148997","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T12:00:47Z","timestamp":1621339247000},"source":"Crossref","is-referenced-by-count":6,"title":["C-peptide enhances glucagon secretion in response to hyperinsulinemia under euglycemic and hypoglycemic conditions"],"prefix":"10.1172","volume":"6","author":[{"given":"Mary Courtney","family":"Moore","sequence":"first","affiliation":[{"name":"Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shana O.","family":"Warner","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufei","family":"Dai","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1338-1052","authenticated-orcid":true,"given":"Nicole","family":"Sheanon","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University of Cincinnati College of Medicine and Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Farmer","sequence":"additional","affiliation":[{"name":"Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca L.","family":"Cason","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8927-2560","authenticated-orcid":true,"given":"Alan D.","family":"Cherrington","sequence":"additional","affiliation":[{"name":"Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason J.","family":"Winnick","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"232","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"issue":"1","key":"B1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jdiacomp.2015.09.003","article-title":"Fear of hypoglycemia in adults with type 1 diabetes: impact of therapeutic advances and strategies for prevention - a review","volume":"30","author":"Martyn-Nemeth","year":"2016","journal-title":"J Diabetes Complications"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116302"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021013"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-2010"},{"issue":"5","key":"B5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2337\/diab.43.5.661","article-title":"Pancreas transplantation in diabetic humans normalizes hepatic glucose production during hypoglycemia","volume":"43","author":"Barrou","year":"1994","journal-title":"Diabetes"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114936"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.49.8.1367"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.7.1942"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1965.00460250053007"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.3.2.261"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117003"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199209033271007"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.2.367"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.3.757"},{"key":"B15"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112784"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-66-6-1220"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107996"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111133"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115340"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1524"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41387-019-0090-0"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2337\/db10-0728"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021873"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(71)90033-3"},{"issue":"1","key":"B26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2337\/diab.26.1.36","article-title":"Abnormalities of endogenous glucagon and insulin in unstable diabetes","volume":"26","author":"Reynolds","year":"1977","journal-title":"Diabetes"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2337\/diab.26.8.717"},{"issue":"1","key":"B28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2337\/diab.37.1.81","article-title":"Correlation between minimal secretory capacity of pancreatic beta-cells and stability of diabetic control","volume":"37","author":"Fukuda","year":"1988","journal-title":"Diabetes"},{"issue":"4","key":"B29","first-page":"976","article-title":"Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1","volume":"77","author":"Johansson","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI134057"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05099-3"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01836"},{"issue":"5 pt 1","key":"B33","first-page":"E651","article-title":"Insulin, glucagon, and catecholamines in prevention of hypoglycemia during fasting","volume":"256","author":"Boyle","year":"1989","journal-title":"Am J Physiol"},{"issue":"4","key":"B34","first-page":"E380","article-title":"Hormonal mechanisms of recovery from insulin-induced hypoglycemia in man","volume":"236","author":"Gerich","year":"1979","journal-title":"Am J Physiol"},{"issue":"6","key":"B35","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2337\/diab.37.6.749","article-title":"Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continuous insulin infusion in conscious dogs","volume":"37","author":"Frizzell","year":"1988","journal-title":"Diabetes"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI40919"},{"issue":"2 Pt 1","key":"B37","first-page":"E206","article-title":"Glucose counterregulation during prolonged hypoglycemia in normal humans","volume":"247","author":"Bolli","year":"1984","journal-title":"Am J Physiol"},{"issue":"6 pt 1","key":"B38","first-page":"E844","article-title":"Contributions of gluconeogenesis and glycogenolysis during glucose counterregulation in normal humans","volume":"256","author":"Lecavalier","year":"1989","journal-title":"Am J Physiol"},{"issue":"6 pt 1","key":"B39","first-page":"E773","article-title":"Role of glucagon in countering hypoglycemia induced by insulin infusion in dogs","volume":"261","author":"Dobbins","year":"1991","journal-title":"Am J Physiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-128-7-199804010-00001"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.3.832"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0881"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12850"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4449-2"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13960"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-1656"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2426"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-2068"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/BF01235858"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4317-0"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/BF00422322"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/BF00572826"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3945\/jn.111.145359"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00100.2019"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1996.tb02042.x"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111036"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109106"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/BF00506536"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111601"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(87)90044-8"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-13-0203"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201540946"},{"issue":"3","key":"B63","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2337\/diab.36.3.382","article-title":"Similar dose responsiveness of hepatic glycogenolysis and gluconeogenesis to glucagon in vivo","volume":"36","author":"Stevenson","year":"1987","journal-title":"Diabetes"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199708)14:8<655::AID-DIA435>3.0.CO;2-G"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1126\/science.182.4108.171"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108502"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1172\/JCI142239"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.48.5.1198"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.12.2948"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.55.03.06.db05-0849"},{"issue":"1","key":"B71","first-page":"E126","article-title":"A negative arterial-portal venous glucose gradient increases net hepatic glucose uptake in euglycemic dogs","volume":"277","author":"Galassetti","year":"1999","journal-title":"Am J Physiol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/24.10.1724"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.8.1872"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00501.2020"},{"issue":"6","key":"B75","first-page":"E987","article-title":"Hepatic glucose uptake rapidly decreases after elimination of the portal signal in conscious dogs","volume":"275","author":"Hsieh","year":"1998","journal-title":"Am J Physiol"},{"issue":"2","key":"B76","first-page":"E295","article-title":"Differential effect of amino acid infusion route on net hepatic glucose uptake in the dog","volume":"276","author":"Moore","year":"1999","journal-title":"Am J Physiol"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/148997\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:47:46Z","timestamp":1779148066000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/148997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":76,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,6,22]]},"published-print":{"date-parts":[[2021,6,22]]}},"alternative-id":["10.1172\/jci.insight.148997"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.148997","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]},"article-number":"e148997"}}